Entries tagged "Sanofi-Aventis"
The healthcare sector was hot in July, with two of the three largest deals of the month: Sanofi-Aventis agreed to pay Merck $4 billion for joint venture Merial, and Bristol-Myers Squibb is buying Medarex for $2.4 billion.
Remember the bird flu? Now that another flu strain is threatening the globe, here's a look at where we stand drugwise.
From VC to licensing, Exelixis has done every kind of deal to keep itself afloat, except one. Is an acquisition next?
2009 has begun better than it might have on the M&A front.
